Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
NCT01106924 - Fructooligosaccharides (FOS) + Inulin-type fructans (ITF) / Inulin + Lacticaseibacillus rhamnosus CGMCC1.3724 vs Placebo & Adiposity / Obesity is a double-blind, placebo-controlled, randomized treatment trial studying Fructooligosaccharides (FOS) + Inulin-type fructans (ITF) / Inulin + Lacticaseibacillus rhamnosus CGMCC1.3724 or placebo in 45 randomized men and 60 randomized women with adiposity / obesity (BMI ≤ 39.9 kg/m^2^) over 24 weeks (1, 2).
Body weight; Body composition (DEXA); Waist circumference
The intention-to-treat analysis revealed that, when considering all subjects, the mean weight loss after the first 12 weeks and after 24 wee…